ACHV Stock Analysis: Buy, Sell, or Hold?
ACHV - Achieve Life Sciences, Inc.
$6.24
0.28 (4.61%)
▲
5d:
+2.05%
30d:
+12.34%
90d:
+29.63%
BUY
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 06, 2026
19d
Get Alerted When ACHV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ACHV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ACHV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ACHV is currently trading at $6.24, which is considered slightly high relative to its 30-day fair value range of $5.39 to $6.37.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $5.76, while resistance sits at $6.66. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.80 (+131.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACHV is in a strong uptrend. Immediate support is located at $5.76, while resistance sits at $6.66. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.80 (+131.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$5.39 -
$6.37
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.6%)
- BULLISH: Trading 131.5% below Wall St target ($13.80)
Trading Range Analysis
30-Day Trading Range
$5.39 -
$6.37
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$5.76
Resistance Level
$6.66
Current Trend
Strong Uptrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.06
Wall Street Target
$13.80
(+131.5%)
Share & Embed Analysis
Last updated: July 17, 2026 3:12 PM ET
Data refreshes hourly during market hours. Next update: 4:12 PM
Data refreshes hourly during market hours. Next update: 4:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACHV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 50 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 51 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
